Kim, J. H., Kim, H., Lee, M. A., Hwang, I. G., Sym, S. J., An, H. J., Kim, T. W., Nam, E. M., Kang, S. Y., Beom, S., Kim, H. S., Shin, S. J., Ahn, J. B. (2026). Bevacizumab-based triplet versus doublet chemotherapy as first-line treatment for metastatic right-sided colon cancer: Results of the KCSG CO19-18 phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15562